Patents Assigned to Aradigm Corporation
  • Patent number: 9372198
    Abstract: The invention provides a method of diagnosing entry of gastrointestinal contents into the respiratory tract of a patient suffering from reflux disease. The method comprises orally administering to a subject formulation comprising a detectable label that is not absorbed from the gastrointestinal tract but can be absorbed from the respiratory tract. The extent of the gastrointestinal contents entering the respiratory tract can be estimated by measuring the level of the detectable label in a body fluid, e.g., blood or urine.
    Type: Grant
    Filed: June 16, 2011
    Date of Patent: June 21, 2016
    Assignees: ARADIGM CORPORATION, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventor: Igor Gonda
  • Publication number: 20160120806
    Abstract: A formulation is disclosed which is comprised of a first solvent having a first active ingredient dissolved therein a plurality of microenvironments dispersed in the first solvent, the microenvironment being comprised of a shell having a dimension in a range of 50 nanometers to 100, the shell comprising an internal volume comprising a second solvent having a second active ingredient dissolved therein and nanocrystals of the second active ingredient.
    Type: Application
    Filed: January 12, 2016
    Publication date: May 5, 2016
    Applicant: ARADIGM CORPORATION
    Inventors: David C. CIPOLLA, Igor GONDA
  • Patent number: 9259424
    Abstract: A concentrated inhalable formulation of an antibiotic drug such as ciprofloxacin is disclosed. The antibiotic is formulated with sodium acetate and liposome which incorporate antibiotic. The formulation is aerosolized and inhaled for treatment of respiratory tract infections and other medical conditions.
    Type: Grant
    Filed: November 25, 2014
    Date of Patent: February 16, 2016
    Assignee: Aradigm Corporation
    Inventors: David C. Cipolla, James Blanchard
  • Publication number: 20150283076
    Abstract: Methods for formulating a liposome comprised of a surfactant and a cryopreservative that can be frozen for long term stability, and upon thawing provides an immediate and sustained release delivery profile. Specific liposome formulations include anti-infectives and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described.
    Type: Application
    Filed: February 11, 2015
    Publication date: October 8, 2015
    Applicant: ARADIGM CORPORATION
    Inventors: David C. CIPOLLA, Igor GONDA
  • Publication number: 20150283133
    Abstract: Methods of treatment of NTM lung infections using formulations of liposomal ciprofloxacin. Specific liposome formulations and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described.
    Type: Application
    Filed: March 31, 2015
    Publication date: October 8, 2015
    Applicants: ARADIGM CORPORATION, OREGON STATE UNIVERSITY
    Inventors: Igor GONDA, James BLANCHARD, David C. CIPOLLA, LUIZ EDUARDO MOREIRA BERMUDEZ
  • Patent number: 9078897
    Abstract: A concentrated inhalable formulation of an antibiotic drug such as ciprofloxacin is disclosed. The antibiotic is formulated with sodium acetate and liposome which incorporate antibiotic. The formulation is aerosolized and inhaled for treatment of respiratory tract infections and other medical conditions.
    Type: Grant
    Filed: April 1, 2015
    Date of Patent: July 14, 2015
    Assignee: ARADIGM CORPORATION
    Inventors: David C. Cipolla, James Blanchard
  • Publication number: 20150168432
    Abstract: A method of diagnosing respiratory fluid in a patient suffering from gastro esophageal reflux disease (GERD) is disclosed. The method comprises (1) orally administering to a subject suspected of suffering from gastro esophageal reflux disease (GERD), a formulation comprised of a plurality of particles comprised of a biocompatible polymer (e.g. carnauba wax) and a detectable, non-radioactive label (e.g. a fluorescent label), (2) allowing the formulation to remain in the subject over a period of time during which the subject would be expected to aspirate the formulation, (3) collecting respiratory fluid from the subject, and (4) analyzing the respiratory fluid to determine if the fluid contains the detectable label, and thereby determining if the subject regurgitates fluid into the respiratory tract.
    Type: Application
    Filed: February 18, 2015
    Publication date: June 18, 2015
    Applicant: Aradigm Corporation
    Inventors: Igor GONDA, Homer A. BOUSHEY
  • Patent number: 9028864
    Abstract: A concentrated inhalable formulation of an antibiotic drug such as ciprofloxacin is disclosed. The antibiotic is formulated with sodium acetate and liposome which incorporate antibiotic. The formulation is aerosolized and inhaled for treatment of respiratory tract infections and other medical conditions.
    Type: Grant
    Filed: September 22, 2010
    Date of Patent: May 12, 2015
    Assignee: Aradigm Corporation
    Inventors: David C. Cipolla, James Blanchard
  • Publication number: 20140261474
    Abstract: The invention relates generally to a system or kit that delivers nicotine to target the regions of the respiratory tract to achieve the maximum impact on craving with a minimum number of unwanted sensations. More specifically, the invention relates to pulmonary administration of nicotine from nicotine inhalation systems that target delivery to the deep lung, minimizing deposition in the upper and central airways.
    Type: Application
    Filed: March 10, 2014
    Publication date: September 18, 2014
    Applicant: ARADIGM CORPORATION
    Inventor: IGOR GONDA
  • Publication number: 20140194504
    Abstract: A method of diagnosing in a subject for the purpose of determining if the subject's gastrointestinal contents has entered the subject's respiratory tract. The qualitative analysis can be also expanded into quantitative analysis, enabling the estimation of either the concentration, or the amount, or both, of the gastrointestinal contents that entered the respiratory tract. The invention also provides methods of treatment based on the identification of aspiration using the methods of the invention.
    Type: Application
    Filed: March 11, 2014
    Publication date: July 10, 2014
    Applicants: The Regents of the University Of California, ARADIGM CORPORATION
    Inventors: Igor Gonda, Homer A. Boushey
  • Publication number: 20140194502
    Abstract: A method of diagnosing in a subject for the purpose of determining if the subject's gastrointestinal contents has entered the subject's respiratory tract. The qualitative analysis can be also expanded into quantitative analysis, enabling the estimation of either the concentration, or the amount, or both, of the gastrointestinal contents that entered the respiratory tract. The invention also provides methods of treatment based on the identification of aspiration using the methods of the invention.
    Type: Application
    Filed: March 11, 2014
    Publication date: July 10, 2014
    Applicant: ARADIGM CORPORATION
    Inventor: Igor Gonda
  • Publication number: 20140194503
    Abstract: A method of diagnosing in a subject for the purpose of determining if the subject's gastrointestinal contents has entered the subject's respiratory tract. The qualitative analysis can be also expanded into quantitative analysis, enabling the estimation of either the concentration, or the amount, or both, of the gastrointestinal contents that entered the respiratory tract. The invention also provides methods of treatment based on the identification of aspiration using the methods of the invention.
    Type: Application
    Filed: March 11, 2014
    Publication date: July 10, 2014
    Applicants: The Regents of the University of California, ARADIGM CORPORATION
    Inventors: Igor Gonda, Homer A. Boushey
  • Publication number: 20140174439
    Abstract: A nozzle comprising a thin, flexible substantially planar polymeric film having a plurality of pores with structures allowing for generation of an aerosol at reduced extrusion pressure is disclosed. The pores can comprise at least two sections, or steps, in which the thickness of the membrane is reduced in stepwise fashion, or the pores can be tapered. Nozzles formed comprising pores having such structures permit aerosol generation at lower extrusion pressures, thereby allowing for decreased weight of aerosolization devices, increased efficiency, increased portability and increased battery life. The pore structures also allow for the use of thicker, more easily processed polymeric films in manufacturing while having a thinner, more efficient aerosolization area. The use of decreased extrusion pressures also results in increased uniformity in aerosol generation and improved reliability of other components.
    Type: Application
    Filed: January 16, 2014
    Publication date: June 26, 2014
    Applicant: ARADIGM CORPORATION
    Inventors: RAJESH S. PATEL, SUDARSAN SRINIVASAN
  • Patent number: 8689803
    Abstract: The invention relates generally to a system and method for treating conditions responsive to nicotine therapy. More specifically, the invention relates to pulmonary administration of a nicotine containing formulation to effect smoking cessation.
    Type: Grant
    Filed: July 31, 2012
    Date of Patent: April 8, 2014
    Assignee: Aradigm Corporation
    Inventor: Igor Gonda
  • Patent number: 8414915
    Abstract: Methods for formulating immediate and sustained release anti-infectives and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described.
    Type: Grant
    Filed: July 13, 2012
    Date of Patent: April 9, 2013
    Assignee: Aradigm Corporation
    Inventors: David C. Cipolla, James Blanchard
  • Patent number: 8381739
    Abstract: The invention relates generally to a system and method for treating conditions responsive to nicotine therapy. More specifically, the invention relates to pulmonary administration of a nicotine containing formulation to effect smoking cessation.
    Type: Grant
    Filed: September 10, 2008
    Date of Patent: February 26, 2013
    Assignee: Aradigm Corporation
    Inventor: Igor Gonda
  • Patent number: 8268347
    Abstract: Methods for formulating immediate and sustained release anti-infectives and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described.
    Type: Grant
    Filed: October 22, 2007
    Date of Patent: September 18, 2012
    Assignee: Aradigm Corporation
    Inventors: David C. Cipolla, James Blanchard
  • Patent number: 8256433
    Abstract: The invention relates generally to a system and method for treating conditions responsive to nicotine therapy. More specifically, the invention relates to pulmonary administration of a nicotine containing formulation to effect smoking cessation.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: September 4, 2012
    Assignee: Aradigm Corporation
    Inventor: Igor Gonda
  • Patent number: 8119156
    Abstract: Methods for formulating immediate and sustained release anti-infectives and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described.
    Type: Grant
    Filed: May 8, 2009
    Date of Patent: February 21, 2012
    Assignee: Aradigm Corporation
    Inventors: David C. Cipolla, James Blanchard
  • Patent number: 8071127
    Abstract: Methods for formulating immediate and sustained release anti-infectives and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described.
    Type: Grant
    Filed: October 30, 2008
    Date of Patent: December 6, 2011
    Assignee: Aradigm Corporation
    Inventors: David C. Cipolla, James Blanchard